Generali Investments Management Co LLC purchased a new position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) during the 4th quarter, HoldingsChannel reports. The fund purchased 1,832 shares of the semiconductor company’s stock, valued at approximately $889,000.
Several other institutional investors have also recently made changes to their positions in the company. Caprock Group LLC boosted its holdings in shares of Synopsys by 0.5% during the fourth quarter. Caprock Group LLC now owns 3,714 shares of the semiconductor company’s stock worth $1,803,000 after purchasing an additional 20 shares during the period. Compagnie Lombard Odier SCmA boosted its holdings in shares of Synopsys by 1.1% during the fourth quarter. Compagnie Lombard Odier SCmA now owns 1,850 shares of the semiconductor company’s stock worth $898,000 after purchasing an additional 20 shares during the period. Edge Capital Group LLC boosted its holdings in shares of Synopsys by 1.2% during the fourth quarter. Edge Capital Group LLC now owns 1,629 shares of the semiconductor company’s stock worth $791,000 after purchasing an additional 20 shares during the period. Barden Capital Management Inc. boosted its holdings in shares of Synopsys by 1.1% during the fourth quarter. Barden Capital Management Inc. now owns 1,832 shares of the semiconductor company’s stock worth $889,000 after purchasing an additional 20 shares during the period. Finally, Resurgent Financial Advisors LLC boosted its holdings in shares of Synopsys by 2.8% during the third quarter. Resurgent Financial Advisors LLC now owns 809 shares of the semiconductor company’s stock worth $410,000 after purchasing an additional 22 shares during the period. Institutional investors own 85.47% of the company’s stock.
Analyst Upgrades and Downgrades
A number of research firms have recently weighed in on SNPS. Robert W. Baird dropped their target price on shares of Synopsys from $644.00 to $630.00 and set an “outperform” rating for the company in a report on Thursday, December 5th. Redburn Atlantic began coverage on shares of Synopsys in a report on Monday, January 13th. They issued a “buy” rating and a $600.00 price objective for the company. Morgan Stanley lowered their price objective on shares of Synopsys from $625.00 to $590.00 and set an “overweight” rating for the company in a report on Monday, February 24th. Rosenblatt Securities restated a “buy” rating and issued a $660.00 price objective on shares of Synopsys in a report on Tuesday, February 25th. Finally, Wells Fargo & Company lowered their price objective on shares of Synopsys from $540.00 to $520.00 and set an “equal weight” rating for the company in a report on Thursday, February 27th. One investment analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat, Synopsys presently has a consensus rating of “Moderate Buy” and an average price target of $638.58.
Synopsys Stock Performance
Shares of NASDAQ SNPS opened at $447.99 on Wednesday. Synopsys, Inc. has a fifty-two week low of $425.73 and a fifty-two week high of $624.80. The company has a 50 day simple moving average of $494.15 and a two-hundred day simple moving average of $507.35. The company has a market capitalization of $69.27 billion, a price-to-earnings ratio of 30.85, a P/E/G ratio of 3.23 and a beta of 1.16.
Insider Buying and Selling at Synopsys
In related news, CRO Richard S. Mahoney sold 20,838 shares of the firm’s stock in a transaction that occurred on Wednesday, January 15th. The shares were sold at an average price of $506.01, for a total transaction of $10,544,236.38. Following the completion of the sale, the executive now owns 1,460 shares of the company’s stock, valued at $738,774.60. This trade represents a 93.45 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Geus Aart De sold 15,705 shares of the firm’s stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $444.42, for a total transaction of $6,979,616.10. Following the sale, the insider now directly owns 116,671 shares of the company’s stock, valued at $51,850,925.82. This trade represents a 11.86 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 47,909 shares of company stock valued at $22,794,835. Corporate insiders own 0.62% of the company’s stock.
Synopsys Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Recommended Stories
- Five stocks we like better than Synopsys
- What is Forex and How Does it Work?
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- Why Are Stock Sectors Important to Successful Investing?
- 3 Must-Own Stocks to Build Wealth This Decade
- Manufacturing Stocks Investing
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.